[Fibrocartilaginous lipoma: a clinicopathological analysis of six cases].

Li, H L; Wang, J; Cheng, H; Zhang, S J; Mao, R J

Li, H L; Wang, J; Cheng, H; Zhang, S J; Mao, R J.

Afiliación

Li HL; Department of Pathology, Foshan Traditional Chinese Medicine Hospital, Foshan 528000, China.
Wang J; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Cheng H; Department of Pathology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhang SJ; Department of Pathology, Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Mao RJ; Department of Pathology, Foshan Traditional Chinese Medicine Hospital, Foshan 528000, China.

Zhonghua Bing Li Xue Za Zhi ; 52(8): 827-831, 2023 Aug 08.

Article en Zh | MEDLINE | ID: mdl-37527988

Asunto(s)

Lipoma; Masculino; Femenino; Humanos; Adulto; Persona de Mediana Edad; Anciano; Desmina/análisis; China; Lipoma/patología; Fibroblastos/patología; Proteínas S100/análisis; Diagnóstico Diferencial; Fibrocartílago/química; Fibrocartílago/patología; Biomarcadores de Tumor/análisis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lipoma Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google